pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    TRX-319
    Primary Progressive Multiple Sclerosis (PPMS) Tr1X Inc
  • Phase 2
    TSC-100
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…$TCRX TScan Therapeutics, Inc.
  • Phase 2
    TSC-101
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…$TCRX TScan Therapeutics, Inc.
  • Phase 2
← prev
page 28 of 50
next →
131
Pain89
Neurology1
TSN-1611
Solid Tumor
Tyligand Biotechnology (Shanghai) Co Ltd
  • Phase 2
    TSRA-196
    Alpha-1 Antitrypsin Deficiency (A1AD) Tessera Therapeutics Inc
  • Phase 2
    TST-003
    Metastatic Colorectal Cancer Transcenta Holding Ltd
  • Phase 2
    TTAX-03
    Osteoarthritis Pain BioTissue Inc
  • Phase 2
    TTHX-1114
    Fuchs Endothelial Corneal Dystrophy (FECD) Trefoil Therapeutics LLC
  • Phase 2
    TTI-101
    Metastatic Hepatocellular Carcinoma (HCC)$TVRD Tvardi Therapeutics, Inc.
  • Phase 2
    TTP-273
    Type 2 Diabetes$VTVT vTv Therapeutics Inc.
  • Phase 2
    TTX-181
    Batten Disease Tern Therapeutics LLC
  • Phase 2
    TTX-333
    Evitar
    Scar Temple Therapeutics BV
  • Phase 2
    TTXMC-138
    Solid Tumor$RNAZ Transcode Therapeutics, Inc.
  • Phase 2
    TUB-040
    Non-Small Cell Lung Cancer Tubulis GmbH
  • Phase 2
    TVI-Kidney-1
    Renal Cell Carcinoma TVAX Biomedical Inc
  • Phase 2
    TX-45
    Pulmonary Hypertension$TECX Tectonic Therapeutic, Inc.
  • Phase 2
    Temferon
    Glioblastoma Multiforme (GBM) Genenta Science SpA
  • Phase 2
    Tolasure
    Epidermolysis Bullosa Simplex Biomendics LLC
  • Phase 2
    Tregcel
    Kidney Transplant Rejection Singulera Therapeutics Inc
  • Phase 2
    UB-311
    Alzheimer's Disease Vaxxinity Inc
  • Phase 2
    UB-941
    Colon Cancer UBI Pharma Inc
  • Phase 2
    UBT-251
    Obesity Novo Nordisk AS
  • Phase 2
    UNDC-005
    Metabolic Dysfunction-Associated Steatohepatitis (MASH or… Myra EB Systems LLC
  • Phase 2
    Umedaptanib Pegol
    Wet (Neovascular / Exudative) Macular Degeneration Ribomic Inc
  • Phase 2
    V-181
    Dengue Fever$MRK Merck & Co., Inc.
  • Phase 2
    VAX-24
    Streptococcal Pneumonia$PCVX Vaxcyte, Inc.
  • Phase 2
    VB-1953
    Acne Vulgaris$HIND Vyome Holdings, Inc
  • Phase 2
    VBC-103
    Metastatic Transitional (Urothelial) Tract Cancer Avenzo Therapeutics Inc
  • Phase 2
    VBI-1901
    Recurrent Glioblastoma Multiforme (GBM) VBI Vaccines Inc
  • Phase 2
    VC-01
    Type 1 Diabetes (Juvenile Diabetes)$VERX Vertex, Inc.